Does that mean that in your assessment, with those resources in place, that if there were 18,000 people at the border tomorrow you would be prepared to meet the medical needs?
Maggie Hassan
The Public Record
Maggie Hassan is an American politician serving as the junior United States senator from New Hampshire since January 3, 2017. A member of the Democratic Party, she previously held the position of the 81st governor of New Hampshire from January 3, 2013, to January 5, 2017. During her tenure as governor, Hassan focused on expanding access to healthcare, improving the state's economy, and addressing issues related to education and infrastructure.
I am also concerned that the continual and likely increased shifting of personnel to the Southern Border will have a detrimental impact on travel, trade, and security along the Northern Border.
I am also obviously concerned that as we stand up more resources at the Southern Border we attend to the security and trade and travel at the Northern Border as well.
I worked with my colleagues in both parties to create a State and local cybersecurity grant program.
I am concerned, I think as we all are, about a resurgence in threats from international terrorism.
My issue is making sure that we have the resources in place and the execution capacity before Title 42 is lifted.
Thank you for coming before the Committee today to discuss critical resources that are needed to protect the homeland.
It is extremely important that we product the cybersecurity of our nation's critical infrastructure too.
If there is no further business to come before the Senate, I ask unanimous consent that it stand adjourned under the previous order. There being no objection, the Senate, at 6:38 p.m., adjourned until Wednesday, April 27, 2022, at 2 p.m…
It is really disturbing that a contractor for the United States Military that is supposed to be there to serve the men and women who serve all of us and keep us safe, and their families, is not complying with longstanding Federal law.
I am deeply concerned by the testimony we have heard today and the impact that similar conduct may have on my constituents.
I want to confirm here; you are saying that no matter what you put in your initial work request, in your experience, Balfour Beatty was able to change the final record, classify the request as they preferred, and say whatever they wanted…
But my question is, what are you doing to make sure that we don't come to a place like this again, and to hold McKinsey accountable for failure to disclose what is an apparent conflict of interest?
I led a bipartisan letter to the FDA, raising concerns about the apparent conflicts of interests surrounding the consulting firm McKinsey.
Well, I am going to hold off on that because I have a few other questions and limited time.
So I am going to follow-up with you additionally, because I am still interested in wanting an answer to whether you are going to suspend contracts, current or future contracts with McKinsey.
For some medications with serious safety concerns, FDA requires manufacturers to set up risk evaluation and mitigation strategies, otherwise known as REMS programs.
And it is using the notion of patient safety to delay the development of additional drugs that could bring down the cost.
REMS has really had two problems with, the first one was we as the generics, as we reverse engineer, need the product that we are reverse engineering to make that.
The Securing a Strong Retirement Act and RISE Act in the House, as well as the Improving Access to Retirement Savings Act--a Senate bill co-sponsored by Senator Maggie Hassan (D-NH) along with Senators Chuck Grassley (R-IA) and James…
I am also going to continue pushing to bring down costs, make our economy work for working families.





